Business & Consumer Services » Shell companies | Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc.
Stock Exchange Other OTC
EPS
$0.04
Market Cap
$70.4 M
Shares Outstanding
67.05 M
Public Float
8.11 M

Profile

Address
248 Route 25A No. 2
East Setauket New York 11733
United States
Employees -
Website http://www.lixte.com
Updated 07/08/2019
Lixte Biotechnology Holdings, Inc. engages in the development of drugs for cancer treatment. It uses biomarker technology to identify enzyme targets associated with serious common diseases and then designs novel compounds to attack those targets. The company was founded by John S.

Financials

View All

John S. Kovach
President, CEO, CFO, Director & CAO
Winson Ho
Director